5 November 2012International Consortium Awarded 6 Million Euro To Validate Pre-Eclampsia Early Detection Tests.More 2 November 2012Genkyotex's NOX Inhibitor GKT137831 Phase I Data Presented at Kidney Week 2012.More 25 October 2012Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury.More 17 October 2012Covagen enters into a strategic research collaboration and 10 October 2012Genocea Closes $30 Million in Series C Financing. The Bill & Melinda Gates Foundation and CVF join as new investors.More 15 August 2012Genocea Initiates a Phase 1/2a Study with its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2)More |
